APA citiranje

Atashrazm, F., & Dzamko, N. (2016). LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: Current perspectives. Clin Pharmacol.

Citação norma Chicago

Atashrazm, Farzaneh, and Nicolas Dzamko. "LRRK2 Inhibitors and Their Potential in the Treatment of Parkinson’s Disease: Current Perspectives." Clin Pharmacol 2016.

MLA citiranje

Atashrazm, Farzaneh, and Nicolas Dzamko. "LRRK2 Inhibitors and Their Potential in the Treatment of Parkinson’s Disease: Current Perspectives." Clin Pharmacol 2016.